Clinical Trials Directory

Trials / Completed

CompletedNCT02006836

Glycemic Responses to Majia Pomelos in Type 2 Diabetic Patients

Glycemic Index & Glycemic Responses to Majia Pomelos

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Food intake has a great influence on blood glucose of patients with diabetes. This study was designed to determine the glycemic index (GI) of a particular pomelo named Majia pomelo and its effects on postprandial glucose (PPG) excursions in both healthy subjects and patients with type 2 diabetes (T2DM).

Detailed description

The purpose of this study was to evaluate the GI and effects on glucose excursion of Majia pomelo in both healthy and diabetic subjects. The results may help diabetic subjects and their health care providers in developing a diet that is both medically and culturally appropriate.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPomeloThe sugar content of the pomelo was 5.86% of full weight, and we use 922g Majia pomelos which contained about 50g sugar equal to 50g glucose for GI measurement.
DIETARY_SUPPLEMENTGlucoseWe dissolved 50 g of glucose in 200 ml water.
OTHERBlankFor the self-control period the diabetic patients underwent 3-day CSII treatment without change of insulin dose and we did not applied any intervention.
DRUGInsulinPatients who were included in the test of glycemic responses to postprandial pomelo consumption were hospitalized with the treatment of Continuous Subcutaneous Insulin Infusion(CSII), and the insulin for CSII was insulin aspart(NovoRapid).
DRUGmet or dietIn diabetic group, 20 diabetic patients were included for GI measurement , 18 of whom were on metformin treatment. Only 2 patients were on diet control due to the early stage of this disease.

Timeline

Start date
2013-01-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2013-12-10
Last updated
2014-06-26
Results posted
2014-06-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02006836. Inclusion in this directory is not an endorsement.